IE
MIST icon

Israel Englander’s Milestone Pharmaceuticals MIST Stock Holding History

Israel Englander’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.21M Buy
3,142,219
+1,597,894
+103% +$2.55M ﹤0.01% 3154
2026
Q1 		$1.84M Buy
1,544,325
+1,141,690
+284% +$2M ﹤0.01% 3948
2025
Q4 		$813K Buy
402,635
+1,076
+0.3% +$2.32K ﹤0.01% 4628
2025
Q3 		$803K Buy
+401,559
New +$706K ﹤0.01% 4780
2025
Q2 		– Sell
-322,082
Closed -$258K – 6166
2025
Q1 		$258K Sell
322,082
-2,381,177
-88% -$4.73M ﹤0.01% 5174
2024
Q4 		$6.38M Sell
2,703,259
-75,266
-3% -$129K ﹤0.01% 2607
2024
Q3 		$4.22M Buy
2,778,525
+28,595
+1% +$41.6K ﹤0.01% 2994
2024
Q2 		$3.66M Sell
2,749,930
-105,682
-4% -$170K ﹤0.01% 3016
2024
Q1 		$5.11M Buy
2,855,612
+1,361,123
+91% +$2.21M ﹤0.01% 2845
2023
Q4 		$2.5M Sell
1,494,489
-200,802
-12% -$545K ﹤0.01% 3423
2023
Q3 		$5.26M Sell
1,695,291
-55,877
-3% -$174K ﹤0.01% 2631
2023
Q2 		$4.99M Buy
1,751,168
+22,146
+1% +$83.5K ﹤0.01% 2673
2023
Q1 		$6.81M Sell
1,729,022
-266,007
-13% -$972K ﹤0.01% 2321
2022
Q4 		$7.9M Buy
1,995,029
+1,061,931
+114% +$5.59M ﹤0.01% 2383
2022
Q3 		$8.57M Sell
933,098
-425,264
-31% -$3.23M 0.01% 2335
2022
Q2 		$8.07M Buy
1,358,362
+69,439
+5% +$427K 0.01% 2290
2022
Q1 		$8.28M Buy
1,288,923
+303,056
+31% +$1.89M ﹤0.01% 2365
2021
Q4 		$6.46M Buy
985,867
+290,626
+42% +$1.74M ﹤0.01% 2637
2021
Q3 		$3.97M Sell
695,241
-23,389
-3% -$132K ﹤0.01% 3137
2021
Q2 		$3.95M Buy
718,630
+833
+0.1% +$4.72K ﹤0.01% 3075
2021
Q1 		$4.16M Buy
717,797
+2,011
+0.3% +$14.7K ﹤0.01% 2781
2020
Q4 		$4.8M Buy
715,786
+408,032
+133% +$2.73M ﹤0.01% 2486
2020
Q3 		$2.25K Buy
+307,754
New +$2.21M ﹤0.01% 2508
2020
Q2 		– Sell
-191,858
Closed -$353K – 4432
2020
Q1 		$353K Buy
191,858
+162,364
+550% +$2.81M ﹤0.01% 3081
2019
Q4 		$472K Buy
29,494
+5,790
+24% +$102K ﹤0.01% 3418
2019
Q3 		$410K Sell
23,704
-10,495
-31% -$207K ﹤0.01% 3383
2019
Q2 		$929K Buy
+34,199
New +$705K ﹤0.01% 2851

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Israel Englander's MIST Position: Q2 2026 in Review

Israel Englander increased its Milestone Pharmaceuticals (MIST) stake by 103% in Q2 2026, buying an estimated $2.55M and bringing the position to 3,142,219 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3154.

Israel Englander first reported a position in MIST in Q2 2019 and has held it in 27 quarters since. The position peaked at $8.57M in Q3 2022. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Israel Englander held 3,142,219 shares of Milestone Pharmaceuticals worth $4.21M as of Q2 2026.
  • Israel Englander bought 1,597,894 Milestone Pharmaceuticals shares in Q2 2026, an estimated $2.55M.
  • Milestone Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3154 holding.
  • Israel Englander first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 27 quarters since.
  • Israel Englander's Milestone Pharmaceuticals position peaked at $8.57M in Q3 2022.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.